Results

Total Results: 1,571 records

Showing results for "discussed".

221. Considering the Range of Decision-Relevant Effects (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
     June 01, 2012 - (Genetic and prognostic tests are discussed further in modules 11 and 12.) Overview Segal JB. … Genetic tests are then further discussed in module 11, while prognostic tests are further discussed in … Patient preference was not discussed. … The other categories of outcomes that were discussed are emotional, social, cognitive, and behavioral

222. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - As discussed in later sections, inclusion of additional countries requires greater resources to support … Patient-Reported Outcomes As discussed in Chapter 5 of the User’s Guide, PROs are defined as “a measurement … Regulatory, Ethical, and Legal Considerations In addition to the planning and design considerations discussed … challenges as other types of registries in the implementation and operational phases; these challenges are discussed … Recruitment and Retention of Patients and Providers As discussed in previous sections, recruitment

223. Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
     February 01, 2013 - The methods used by the EPC program at this earlier stage are discussed elsewhere.11 Likewise, we recognize … The two stages of assessment are discussed in more detail below. … gray literature documents for eligibility in the SR using the key questions and inclusion criteria as discussed … EPC reviewers should have discussed and established a priori guidance on when to include specific types … bias in study selection overlap with considerations to reduce bias when defining the key questions (discussed

224. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Peer Reviewer #2 Discussion and Conclusions - Implications/findings are clearly discussed - Would

225. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - population is explicitly defined, and the limitations of defining the target population in JIA are nicely discussed … These latter two cases are not discussed or counted among the JIA patients with malignancies, and Imundo … Peer Reviewer #7 Results (KQ 5) One composite measure which was not discussed and specifically excluded … Methotrexate, which has a greater body of evidence, is now discussed in greater detail.

226. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
     December 15, 2015 - studies were published as we as when the data was collected are noted in the abstraction as this is discussed … the name of a technical mechanism developed by ONC using an email-like understructure-- it is often discussed … exchange of patient-level data including access to prior laboratory results and radiology reports (as discussed … report I thought of several important ideas for follow-up studies based on limitations and gaps they discussed

227. Disposition of Comments_CER 231 Care Interventions for People Living With Dementia and Their Caregivers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-231-dementia-care-interventions-disposition-comments.pdf
     July 31, 2020 - and Conclusions Factors such as dementia type, race, sexual orientation, and economic status were discussed … The variable use of study endpoints to measure performance is never really discussed as part of the … The Best Practice Caregiving resource is discussed in Chapter 9 and highlighted again in Chapter 10 … as well as accessibility, transportation, culture, race and related factors should be explored and discussed

228. Emerging MRI Technologies for Imaging Musculoskeletal Disorders under Loading Stress (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
     November 01, 2011 - As discussed in response to relevant comments above, by the very nature the Technical Brief, a strict … Reviewer 3 (Results) Findings, page 20, line 37 Implications of lower strength need to be briefly discussed … [sic] As discussed in regards to previous comments, it is beyond the scope of this Technical Brief … [sic] As discussed above, it is beyond the scope of the Technical brief to provide a detailed step-by-step … As discussed above, the inclusion of dedicated extremity MRI was based on input from Key Informants

229. Gastric-Cancers-Supplementary-App-I (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
     January 01, 2019 - ICEMAN - Primary studies RefID Study name State a single candidate effect modifier Was the effect modifier measured before or at randomization/assignment? State a single outcome and time-point of interest State a single effect measure 1: Was the direction of the effect modification correctly hypothesized a priori? 1: …

230. Disposition of Comments for Technical Brief 18 Public Reporting of Cost Measures in Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-cost-measures_disposition-comments.pdf
     March 05, 2015 - The rational is now discussed in the brief. 30. … We tested the concordance between two reviewers and discussed the discordance. 34. … This concept has been discussed in the literature; patients’ abilities to review their providers as

231. Disposition of Comments_Comparative Effectiveness Review NO. 243: Prehospital Airway Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-disposition-comments.pdf
     June 14, 2021 - Was BVM in the studies discussed in the draft review paper uniformly accompanied by NPA or OPA use? … As you discussed in the paper, the evidence is of inherently limited quality and statistical strength

232. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - TEP reviewer #3 I am glad you discussed the strength of evidence categories and how they were defined … The combination of BUD/Form is not approved for children under 12 but efficacy and safety studies discussed … Also, the parameters for these studies were not discussed in regards to 3 hour peak.

233. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - The points discussed in the executive summary should mirror the input into the questions. … comparative RCTs on healing of EE and other objective parameters noted in the question so that the points discussed … specific studies are cited, referencing would allow the reader to more fully explore the concepts being discussed

234. Disposition of Comments for CER 204 Methods for Evaluating Natural Experiments in Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-204-obesity-disposition-comments.pdf
     December 01, 2017 - Was it discussed by the team? … As I already noted, quality issues related to diet and PA were not discussed in the review (although

235. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - inclusion and exclusion criteria were adapted from the original 2008 report and were extensively discussed … We discussed all subgroups in our Results section and also provided the SOE grading for each subgroup … terms and require longer to accrue...thus any harms would weigh even more importantly...this should be discussed … harm and costs more (mutliple decision and cost analyses have demonstrated this)....this could be discussed … inclusion and exclusion criteria were adapted from the original 2008 report and were extensively discussed

236. Thompson_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/thompson_eccs2012.pdf
     January 01, 2012 - Thompson_ECCS2012 Slide 1: Evidential Preferences  andWhoWe Trust: Health  Education  and Decision Making Vetta L. Sanders Thompson, PhD, MA Associate Professor Washington  University,  Brown  School,  St. Louis,  MO Slide 2: In…

237. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
     May 01, 2024 - o The TEP discussed the lack of evidence on benefits of the care transition PSPs for safety outcomes

238. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
     December 01, 2011 - The opinion that you expressed is best discussed in an active surveillance consensus conference. … while these are generally short-term and reflect only progression using definitions with limitations discussed

239. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
     August 11, 2014 - We discussed the lack of temporal trends in the report text.

240. Disposition of Comments_Comparative Effectiveness Review No. 275: Healthcare Delivery of Clinical Preventive Services for People With Disabilities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-275-people-with-disabilities-disposition-comments.pdf
     September 16, 2024 - question 1 would benefit from citations so that interested readers can easily identify the studies being discussed